Literature DB >> 27440892

Human Cathelicidin Compensates for the Role of Apolipoproteins in Hepatitis C Virus Infectious Particle Formation.

Francesc Puig-Basagoiti1, Takasuke Fukuhara1, Tomokazu Tamura1, Chikako Ono1, Kentaro Uemura1, Yukako Kawachi1, Satomi Yamamoto1, Hiroyuki Mori1, Takeshi Kurihara1, Toru Okamoto1, Hideki Aizaki2, Yoshiharu Matsuura3.   

Abstract

UNLABELLED: Exchangeable apolipoproteins (ApoA, -C, and -E) have been shown to redundantly participate in the formation of infectious hepatitis C virus (HCV) particles during the assembly process, although their precise role in the viral life cycle is not well understood. Recently, it was shown that the exogenous expression of only short sequences containing amphipathic α-helices from various apolipoproteins is sufficient to restore the formation of infectious HCV particles in ApoB and ApoE double-gene-knockout Huh7 (BE-KO) cells. In this study, through the expression of a small library of human secretory proteins containing amphipathic α-helix structures, we identified the human cathelicidin antimicrobial peptide (CAMP), the only known member of the cathelicidin family of antimicrobial peptides (AMPs) in humans and expressed mainly in bone marrow and leukocytes. We showed that CAMP is able to rescue HCV infectious particle formation in BE-KO cells. In addition, we revealed that the LL-37 domain in CAMP containing amphipathic α-helices is crucial for the compensation of infectivity in BE-KO cells, and the expression of CAMP in nonhepatic 293T cells expressing claudin 1 and microRNA miR-122 confers complete propagation of HCV. These results suggest the possibility of extrahepatic propagation of HCV in cells with low-level or no expression of apolipoproteins but expressing secretory proteins containing amphipathic α-helices such as CAMP. IMPORTANCE: Various exchangeable apolipoproteins play a pivotal role in the formation of infectious HCV during the assembly of viral particles, and amphipathic α-helix motifs in the apolipoproteins have been shown to be a key factor. To the best of our knowledge, we have identified for the first time the human cathelicidin CAMP as a cellular protein that can compensate for the role of apolipoproteins in the life cycle of HCV. We have also identified the domain in CAMP that contains amphipathic α-helices crucial for compensation and show that the expression of CAMP in nonhepatic cells expressing claudin 1 and miR-122 confers complete propagation of HCV. We speculate that low levels of HCV propagation might be possible in extrahepatic tissues expressing secretory proteins containing amphipathic α-helices without the expression of apolipoproteins.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27440892      PMCID: PMC5021414          DOI: 10.1128/JVI.00471-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  81 in total

1.  A guided tour into subcellular colocalization analysis in light microscopy.

Authors:  S Bolte; F P Cordelières
Journal:  J Microsc       Date:  2006-12       Impact factor: 1.758

2.  The J6JFH1 strain of hepatitis C virus infects human B-cells with low replication efficacy.

Authors:  Masato Nakai; Tsukasa Seya; Misako Matsumoto; Kunitada Shimotohno; Naoya Sakamoto; Hussein H Aly
Journal:  Viral Immunol       Date:  2014-05-22       Impact factor: 2.257

Review 3.  Apolipoprotein A-I: structure-function relationships.

Authors:  P G Frank; Y L Marcel
Journal:  J Lipid Res       Date:  2000-06       Impact factor: 5.922

4.  Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium.

Authors:  Koji Hase; Lars Eckmann; John D Leopard; Nissi Varki; Martin F Kagnoff
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

5.  Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription.

Authors:  Takahiro Masaki; Ryosuke Suzuki; Mohsan Saeed; Ken-ichi Mori; Mami Matsuda; Hideki Aizaki; Koji Ishii; Noboru Maki; Tatsuo Miyamura; Yoshiharu Matsuura; Takaji Wakita; Tetsuro Suzuki
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

6.  Reconstitution of the entire hepatitis C virus life cycle in nonhepatic cells.

Authors:  Daniel Da Costa; Marine Turek; Daniel J Felmlee; Erika Girardi; Sébastien Pfeffer; Gang Long; Ralf Bartenschlager; Mirjam B Zeisel; Thomas F Baumert
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

Review 7.  The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function.

Authors:  J P Segrest; M K Jones; H De Loof; C G Brouillette; Y V Venkatachalapathi; G M Anantharamaiah
Journal:  J Lipid Res       Date:  1992-02       Impact factor: 5.922

8.  Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3.

Authors:  O E Sørensen; P Follin; A H Johnsen; J Calafat; G S Tjabringa; P S Hiemstra; N Borregaard
Journal:  Blood       Date:  2001-06-15       Impact factor: 22.113

9.  Ontology-based meta-analysis of global collections of high-throughput public data.

Authors:  Ilya Kupershmidt; Qiaojuan Jane Su; Anoop Grewal; Suman Sundaresh; Inbal Halperin; James Flynn; Mamatha Shekar; Helen Wang; Jenny Park; Wenwu Cui; Gregory D Wall; Robert Wisotzkey; Satnam Alag; Saeid Akhtari; Mostafa Ronaghi
Journal:  PLoS One       Date:  2010-09-29       Impact factor: 3.240

10.  Antiviral lectins from red and blue-green algae show potent in vitro and in vivo activity against hepatitis C virus.

Authors:  Yutaka Takebe; Carrie J Saucedo; Garry Lund; Rie Uenishi; Saiki Hase; Takayo Tsuchiura; Norman Kneteman; Koreen Ramessar; D Lorne J Tyrrell; Masayuki Shirakura; Takaji Wakita; James B McMahon; Barry R O'Keefe
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more
  9 in total

1.  Characterization of Recombinant Flaviviridae Viruses Possessing a Small Reporter Tag.

Authors:  Tomokazu Tamura; Takasuke Fukuhara; Takuro Uchida; Chikako Ono; Hiroyuki Mori; Asuka Sato; Yuzy Fauzyah; Toru Okamoto; Takeshi Kurosu; Yin Xiang Setoh; Michio Imamura; Norbert Tautz; Yoshihiro Sakoda; Alexander A Khromykh; Kazuaki Chayama; Yoshiharu Matsuura
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

Review 2.  Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact.

Authors:  Emilie Crouchet; Thomas F Baumert; Catherine Schuster
Journal:  Expert Rev Proteomics       Date:  2017-06-30       Impact factor: 4.250

3.  Hepatitis C Virus Strain-Dependent Usage of Apolipoprotein E Modulates Assembly Efficiency and Specific Infectivity of Secreted Virions.

Authors:  Romy Weller; Kathrin Hueging; Richard J P Brown; Daniel Todt; Sebastian Joecks; Florian W R Vondran; Thomas Pietschmann
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

4.  Host-derived apolipoproteins play comparable roles with viral secretory proteins Erns and NS1 in the infectious particle formation of Flaviviridae.

Authors:  Takasuke Fukuhara; Tomokazu Tamura; Chikako Ono; Mai Shiokawa; Hiroyuki Mori; Kentaro Uemura; Satomi Yamamoto; Takeshi Kurihara; Toru Okamoto; Ryosuke Suzuki; Kentaro Yoshii; Takeshi Kurosu; Manabu Igarashi; Hiroshi Aoki; Yoshihiro Sakoda; Yoshiharu Matsuura
Journal:  PLoS Pathog       Date:  2017-06-23       Impact factor: 6.823

Review 5.  Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design.

Authors:  Florian Wrensch; Emilie Crouchet; Gaetan Ligat; Mirjam B Zeisel; Zhen-Yong Keck; Steven K H Foung; Catherine Schuster; Thomas F Baumert
Journal:  Front Immunol       Date:  2018-06-21       Impact factor: 8.786

Review 6.  HCV Pit Stop at the Lipid Droplet: Refuel Lipids and Put on a Lipoprotein Coat before Exit.

Authors:  Gabrielle Vieyres; Thomas Pietschmann
Journal:  Cells       Date:  2019-03-12       Impact factor: 6.600

Review 7.  HCV Interplay with Lipoproteins: Inside or Outside the Cells?

Authors:  François-Loïc Cosset; Chloé Mialon; Bertrand Boson; Christelle Granier; Solène Denolly
Journal:  Viruses       Date:  2020-04-12       Impact factor: 5.048

8.  The ATGL lipase cooperates with ABHD5 to mobilize lipids for hepatitis C virus assembly.

Authors:  Gabrielle Vieyres; Isabelle Reichert; Arnaud Carpentier; Florian W R Vondran; Thomas Pietschmann
Journal:  PLoS Pathog       Date:  2020-06-15       Impact factor: 6.823

Review 9.  Immunomodulatory Role of the Antimicrobial LL-37 Peptide in Autoimmune Diseases and Viral Infections.

Authors:  Bapi Pahar; Stefania Madonna; Arpita Das; Cristina Albanesi; Giampiero Girolomoni
Journal:  Vaccines (Basel)       Date:  2020-09-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.